SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Lee DM, Weinblatt ME.Rheumatoid arthritis.Lancet2001;358:90311.
  • 2
    Gregersen PK, Silver J, Winchester RJ.The shared epitope hypothesis: an approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis.Arthritis Rheum1987;30:120513.
  • 3
    Begovich AB, Carlton VE, Honigberg LA, Schrodi SJ, Chokkalingam AP, Alexander HC, et al.A missense single-nucleotide polymorphism in a gene encoding a protein tyrosine phosphatase (PTPN22) is associated with rheumatoid arthritis.Am J Hum Genet2004;75:3307.
  • 4
    Wellcome Trust Case Control Consortium.Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls.Nature2007;447:66178.
  • 5
    Karlson EW, Chibnik LB, Cui J, Plenge RM, Glass RJ, Maher NE, et al.Associations between human leukocyte antigen, PTPN22, CTLA4 genotypes and rheumatoid arthritis phenotypes of autoantibody status, age at diagnosis and erosions in a large cohort study.Ann Rheum Dis2008;67:35863.
  • 6
    Genovese MC, Becker JC, Schiff M, Luggen M, Sherrer Y, Kremer J, et al.Abatacept for rheumatoid arthritis refractory to tumor necrosis factor α inhibition.N Engl J Med2005;353:111423.
  • 7
    Wang B, Andre I, Gonzalez A, Katz JD, Aguet M, Benoist C, et al.Interferon-γ impacts at multiple points during the progression of autoimmune diabetes.Proc Natl Acad Sci U S A1997;94:138449.
  • 8
    Komiyama Y, Nakae S, Matsuki T, Nambu A, Ishigame H, Kakuta S, et al.IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis.J Immunol2006;177:56673.
  • 9
    Hirota K, Yoshitomi H, Hashimoto M, Maeda S, Teradaira S, Sugimoto N, et al.Preferential recruitment of CCR6-expressing Th17 cells to inflamed joints via CCL20 in rheumatoid arthritis and its animal model.J Exp Med2007;204:280312.
  • 10
    Manoury-Schwartz B, Chiocchia G, Bessis N, Abehsira-Amar O, Batteux F, Muller S, et al.High susceptibility to collagen-induced arthritis in mice lacking IFN-γ receptors.J Immunol1997;158:55016.
  • 11
    PDL BioPharma, sponsor. A phase 2 study to evaluate the safety, tolerability, and activity of fontolizumab in subjects with active rheumatoid arthritis. ClinialTrials.gov identifier: NCT00281294;2008.
  • 12
    Genovese MC, van den Bosch F, Roberson SA, Bojin S, Biagini IM, Ryan P, et al.LY2439821, a humanized anti–interleukin-17 monoclonal antibody, in the treatment of patients with rheumatoid arthritis: a phase I randomized, double-blind, placebo-controlled, proof-of-concept study.Arthritis Rheum2010;62:92939.
  • 13
    Hueber W, Patel DD, Dryja T, Wright AM, Koroleva I, Bruin G, et al.Effects of AIN457, a fully human antibody to interleukin-17A, on psoriasis, rheumatoid arthritis, and uveitis.Sci Transl Med2010;2:52ra72.
  • 14
    Yamada H, Nakashima Y, Okazaki K, Mawatari T, Fukushi J, Kaibara N, et al.Th1 but not Th17 cells predominate in the joints of patients with rheumatoid arthritis.Ann Rheum Dis2008;67:1299304.
  • 15
    Hueber AJ, Asquith DL, Miller AM, Reilly J, Kerr S, Leipe J, et al.Mast cells express IL-17A in rheumatoid arthritis synovium.J Immunol2010;184:333640.
  • 16
    Suurmond J, Dorjee AL, Boon MR, Knol EF, Huizinga TW, Toes RE, et al.Mast cells are the main interleukin 17-positive cells in anticitrullinated protein antibody-positive and -negative rheumatoid arthritis and osteoarthritis synovium.Arthritis Res Ther2011;13:R150.
  • 17
    Takemura S, Braun A, Crowson C, Kurtin PJ, Cofield RH, O'Fallon WM, et al.Lymphoid neogenesis in rheumatoid synovitis.J Immunol2001;167:107280.
  • 18
    Corsiero E, Bombardieri M, Manzo A, Bugatti S, Uguccioni M, Pitzalis C.Role of lymphoid chemokines in the development of functional ectopic lymphoid structures in rheumatic autoimmune diseases.Immunol Lett2012;145:627.
  • 19
    Forster R, Mattis AE, Kremmer E, Wolf E, Brem G, Lipp M.A putative chemokine receptor, BLR1, directs B cell migration to defined lymphoid organs and specific anatomic compartments of the spleen.Cell1996;87:103747.
  • 20
    Shi K, Hayashida K, Kaneko M, Hashimoto J, Tomita T, Lipsky PE, et al.Lymphoid chemokine B cell-attracting chemokine-1 (CXCL13) is expressed in germinal center of ectopic lymphoid follicles within the synovium of chronic arthritis patients.J Immunol2001;166:6505.
  • 21
    Gunn MD, Ngo VN, Ansel KM, Ekland EH, Cyster JG, Williams LT.A B-cell-homing chemokine made in lymphoid follicles activates Burkitt's lymphoma receptor-1.Nature1998;391:799803.
  • 22
    Crotty S.Follicular helper CD4 T cells (T-FH).Annu Rev Immunol2011;29:62163.
  • 23
    Manzo A, Vitolo B, Humby F, Caporali R, Jarrossay D, Dell'Accio F, et al.Mature antigen-experienced T helper cells synthesize and secrete the B cell chemoattractant CXCL13 in the inflammatory environment of the rheumatoid joint.Arthritis Rheum2008;58:337787.
  • 24
    Rasheed AU, Rahn HP, Sallusto F, Lipp M, Muller G.Follicular B helper T cell activity is confined to CXCR5hiICOShi CD4 T cells and is independent of CD57 expression.Eur J Immunol2006;36:1892903.
  • 25
    Takagi R, Higashi T, Hashimoto K, Nakano K, Mizuno Y, Okazaki Y, et al.B cell chemoattractant CXCL13 is preferentially expressed by human Th17 cell clones.J Immunol2008;181:1869.
  • 26
    Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al.The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis.Arthritis Rheum1988;31:31524.
  • 27
    Bossaller L, Burger J, Draeger R, Grimbacher B, Knoth R, Plebani A, et al.ICOS deficiency is associated with a severe reduction of CXCR5+CD4 germinal center Th cells.J Immunol2006;177:492732.
  • 28
    Johnston RJ, Poholek AC, DiToro D, Yusuf I, Eto D, Barnett B, et al.Bcl6 and Blimp-1 are reciprocal and antagonistic regulators of T follicular helper cell differentiation.Science2009;325:100610.
  • 29
    Nurieva RI, Chung Y, Hwang D, Yang XO, Kang HS, Ma L, et al.Generation of T follicular helper cells is mediated by interleukin-21 but independent of T helper 1, 2, or 17 cell lineages.Immunity2008;29:13849.
  • 30
    Haynes NM, Allen CD, Lesley R, Ansel KM, Killeen N, Cyster JG.Role of CXCR5 and CCR7 in follicular Th cell positioning and appearance of a programmed cell death gene-1high germinal center-associated subpopulation.J Immunol2007;179:5099108.
  • 31
    Maini R, St Clair EW, Breedveld F, Furst D, Kalden J, Weisman M, et al, the ATTRACT Study Group.Infliximab (chimeric anti-tumour necrosis factor α monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial.Lancet1999;354:19329.
  • 32
    Nishimoto N, Yoshizaki K, Miyasaka N, Yamamoto K, Kawai S, Takeuchi T, et al.Treatment of rheumatoid arthritis with humanized anti–interleukin-6 receptor antibody: a multicenter, double-blind, placebo-controlled trial.Arthritis Rheum2004;50:17619.
  • 33
    Firestein GS, Alvaro-Gracia JM, Maki R.Quantitative analysis of cytokine gene expression in rheumatoid arthritis.J Immunol1990;144:334753.
  • 34
    Prevoo ML, van ‘t Hof MA, Kuper HH, van Leeuwen MA, van de Putte LB, van Riel PL.Modified disease activity scores that include twenty-eight–joint counts: development and validation in a prospective longitudinal study of patients with rheumatoid arthritis.Arthritis Rheum1995;38:448.
  • 35
    Morita R, Schmitt N, Bentebibel SE, Ranganathan R, Bourdery L, Zurawski G, et al.Human blood CXCR5+CD4+ T cells are counterparts of T follicular cells and contain specific subsets that differentially support antibody secretion.Immunity2011;34:10821.
  • 36
    Humby F, Bombardieri M, Manzo A, Kelly S, Blades MC, Kirkham B, et al.Ectopic lymphoid structures support ongoing production of class-switched antibodies in rheumatoid synovium.PLoS Med2009;6:e1.
  • 37
    Henry RA, Kendall PL.CXCL13 blockade disrupts B lymphocyte organization in tertiary lymphoid structures without altering B cell receptor bias or preventing diabetes in nonobese diabetic mice.J Immunol2010;185:14605.
  • 38
    Grabner R, Lotzer K, Dopping S, Hildner M, Radke D, Beer M, et al.Lymphotoxin β receptor signaling promotes tertiary lymphoid organogenesis in the aorta adventitia of aged ApoE−/− mice.J Exp Med2009;206:23348.
  • 39
    Luther SA, Ansel KM, Cyster JG.Overlapping roles of CXCL13, interleukin 7 receptor α, and CCR7 ligands in lymph node development.J Exp Med2003;197:11918.
  • 40
    Nakayamada S, Kanno Y, Takahashi H, Jankovic D, Lu KT, Johnson TA, et al.Early Th1 cell differentiation is marked by a Tfh cell-like transition.Immunity2011;35:91931.
  • 41
    Sage PT, Francisco LM, Carman CV, Sharpe AH.The receptor PD-1 controls follicular regulatory T cells in the lymph nodes and blood.Nat Immunol2013;14:15261.
  • 42
    Schroder AE, Greiner A, Seyfert C, Berek C.Differentiation of B cells in the nonlymphoid tissue of the synovial membrane of patients with rheumatoid arthritis.Proc Natl Acad Sci U S A1996;93:2215.